Antitoxin Use in the Prevention and Treatment of Anthrax Disease: A Systematic Review.

Elisabeth M HesseShana Godfred-CatoWilliam A Bower

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)

Limited human and animal evidence indicates that adjunctive antitoxin treatment may improve survival from systemic anthrax infection. Antitoxins may also provide an alternative therapy to antimicrobials for treatment or PEP during an intentional anthrax incident that could involve a multidrug-resistant B. anthracis strain.

Keyphrases

multidrug resistant
cardiovascular disease
endothelial cells
stem cells
type diabetes
drug resistant
combination therapy
acinetobacter baumannii
gram negative
smoking cessation